These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 3801570)

  • 21. Changes in pH associated with clotting of fibrinogen. Kinetic studies of the pH shift and correlation of the pH change with the release of fibrinopeptides and the ensuing polymerization.
    Mihalyi E; Tercero JC; Diaz-Mauriño T
    Biochemistry; 1991 May; 30(19):4753-62. PubMed ID: 2029517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.
    Galanakis DK; Ghebrehiwet B
    J Clin Invest; 1994 Jan; 93(1):303-10. PubMed ID: 8282801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of divalent cations on the conversion of fibrinogen to fibrin and fibrin polymerization.
    Kanaide H; Uranishi T; Nakamura M
    Am J Hematol; 1982 Nov; 13(3):229-37. PubMed ID: 7180836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ioxaglate--an ionic low osmolar contrast medium--on fibrin polymerization in vitro.
    Brass O; Belleville J; Sabattier V; Corot C
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):689-97. PubMed ID: 8292718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.
    Litvinov RI; Yakovlev S; Tsurupa G; Gorkun OV; Medved L; Weisel JW
    Biochemistry; 2007 Aug; 46(31):9133-42. PubMed ID: 17630702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of thrombin and fibrinogen and the polymerization of fibrin monomer.
    Scheraga HA
    Ann N Y Acad Sci; 1983 Jun; 408():330-43. PubMed ID: 6575693
    [No Abstract]   [Full Text] [Related]  

  • 27. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen.
    Gorkun OV; Veklich YI; Weisel JW; Lord ST
    Blood; 1997 Jun; 89(12):4407-14. PubMed ID: 9192765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrin polymerization and release of fibrinopeptide B by thrombin.
    Hurlet-Jensen A; Cummins HZ; Nossel HL; Liu CY
    Thromb Res; 1982 Aug; 27(4):419-27. PubMed ID: 7147212
    [No Abstract]   [Full Text] [Related]  

  • 29. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
    Francis CW; Bunce LA; Sporn LA
    Blood Cells; 1993; 19(2):291-306; discussion 306-7. PubMed ID: 8312565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinopeptide B and aggregation of fibrinogen.
    Shainoff JR; Dardik BN
    Science; 1979 Apr; 204(4389):200-2. PubMed ID: 155308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations.
    Mihalyi E
    Biochemistry; 1988 Feb; 27(3):976-82. PubMed ID: 3365374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer.
    Dardik BN; Shainoff JR
    Blood; 1985 Mar; 65(3):680-8. PubMed ID: 3971045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates.
    Hogg PJ; Jackson CM
    J Biol Chem; 1990 Jan; 265(1):248-55. PubMed ID: 2294105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions.
    Bini A; Fenoglio J; Sobel J; Owen J; Fejgl M; Kaplan KL
    Blood; 1987 Apr; 69(4):1038-45. PubMed ID: 2950941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the location in the thrombin B chain of substrate recognition sites for fibrinopeptide release and factor XIII activation.
    Pirkle H; Theodor I; Christofferson M; Vukasin P; Miyada D
    Thromb Res; 1989 Sep; 55(6):737-46. PubMed ID: 2781534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
    Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for four different polymerization sites involved in human fibrin formation.
    Olexa SA; Budzynski AZ
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1374-8. PubMed ID: 6929491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.